首頁 > 市場調查報告書 > 醫療設備

體外診斷設備契約製造市場規模、佔有率和成長分析（按產品類型、技術、服務類型和地區分類）－2026年至2033年產業預測

市場調查報告書

商品編碼

1900460

體外診斷設備契約製造市場規模、佔有率和成長分析（按產品類型、技術、服務類型和地區分類）－2026年至2033年產業預測

IVD Contract Manufacturing Market Size, Share, and Growth Analysis, By Product Type (Consumables, Equipment), By Technology (Immunoassays, Clinical Chemistry), By Service Type, By Region -Industry Forecast 2026-2033.

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 194 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，體外診斷設備 (IVD)契約製造市場規模將達到 184.4 億美元，到 2025 年將達到 205.7 億美元，到 2033 年將達到 495.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 11.6%。

體外診斷（IVD）契約製造市場預計將迎來顯著成長，這主要得益於人們對個人化醫療、基因表現和生物標記發現日益成長的興趣。這一趨勢正在推動對標準化診斷解決方案的需求，尤其是在醫療成本持續上漲的新興市場。數位病理學、次世代定序和先進成像等診斷技術的進步進一步推動了對創新診斷方法的需求。從個人化妊娠測試到複雜的臨床檢測，種類繁多的體外診斷產品正在推動市場動態。此外，製藥業對體外診斷設備的日益普及以及對照護現場檢測（POCT）的日益關注也促進了市場擴張。主要參與者之間的合作將在該行業的發展中發揮關鍵作用。

全球體外診斷（IVD）契約製造市場按產品類型、技術、服務類型和地區進行細分。依產品類型分類，可分為耗材和設備。依技術分類，可分為免疫檢測、臨床化學、分子診斷、血液學、微生物學、凝血與止血等技術。依服務類型分類，可分為生產服務、檢測開發及其他服務。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

體外診斷契約製造市場的成長要素

糖尿病、癌症和心臟病等慢性疾病的日益流行，顯著推動了對先進體外診斷（IVD）設備的需求。這種需求的激增，加上製造商為有效應對全球健康挑戰而努力提高生產效率，共同推動了IVD契約製造市場的成長。在此背景下，契約製造製造商在為IVD公司提供具成本效益、高品質的解決方案以及幫助其滿足嚴格的監管要求方面發揮著至關重要的作用。隨著醫療需求的不斷演變，IVD公司與契約製造之間的合作變得日益重要，以確保創新診斷工具的供應，從而應對緊迫的健康問題。

體外診斷契約製造市場的限制

體外診斷（IVD）契約製造市場面臨巨大的成本挑戰。體外診斷醫療設備的研發和生產過程需要在研發、法規遵循和生產基礎設施方面投入大量資金。這些高昂的成本會阻礙中小企業進入市場，使其難以進入，並阻礙整個產業的成長。因此，與創新和產能相關的財務負擔會限制競爭和新技術的應用，從而影響體外診斷領域的市場動態和潛在發展。

體外診斷契約製造市場的發展趨勢

體外診斷（IVD）契約製造市場的一大趨勢是將生產外包給新興市場，尤其是亞太地區。由於這些地區人事費用低廉且擁有大量熟練人才，能夠實現高效的生產流程，企業正在加速向這些地區擴張。這種轉變不僅有助於降低營運成本，也為製造商提供了機遇，使其能夠掌握快速成長市場對體外診斷產品日益成長的需求。因此，對具成本效益生產解決方案和熟練勞動力的關注正在重塑體外診斷產業，並推動其成長和創新。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Jabil Inc.
Sanmina Corporation
TE Connectivity
Celestica, Inc.
West Pharmaceutical Services, Inc.
Savyon Diagnostics, Ltd.
KMC Systems
Cenogenics Corporation
Nova Biomedical
Cone Bioproducts
Kimball Electronics, Inc.
Roche Diagnostics
Viant Medical Holdings, Inc.
Sysmex Corporation
Stratec SE
Thermo Fisher Scientific, Inc.
Fujirebio
Biokit（Werfen）
Sekisui
Prestige Diagnostics

結論與建議

簡介目錄

Product Code: SQMIG35H2317

IVD Contract Manufacturing Market size was valued at USD 18.44 Billion in 2024 and is poised to grow from USD 20.57 Billion in 2025 to USD 49.51 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026-2033).

The IVD contract manufacturing market is poised for significant growth, fueled by the rising focus on personalized medicine, gene expression, and biomarker discovery. This trend is propelling demand for standardized diagnostic solutions, particularly in emerging markets where healthcare costs continue to climb. Advancements in diagnostic technologies like digital pathology, next-generation sequencing, and advanced imaging are further driving the need for innovative diagnostics. A diverse array of in vitro diagnostics, from personalized pregnancy tests to complex clinical assays, enhances market dynamics. Additionally, the increasing adoption of IVD devices within the pharmaceutical sector and the rising interest in point-of-care monitoring contribute to the market's expansion. Collaboration among key players will play a crucial role in advancing this segment of the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the IVD Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

IVD Contract Manufacturing Market Segments Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region. By Product Type, the market is classified into Consumables, and Equipment. Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies. According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the IVD Contract Manufacturing Market

The rising prevalence of chronic conditions like diabetes, cancer, and heart disease is significantly boosting the demand for sophisticated In Vitro Diagnostics (IVD) devices. This surge is propelling the growth of the IVD contract manufacturing market, as manufacturers strive to enhance productivity to tackle global health challenges effectively. In this context, contract manufacturers are essential in delivering cost-efficient, high-quality solutions to IVD companies, enabling them to comply with stringent regulatory requirements. As healthcare needs evolve, the partnership between IVD firms and contract manufacturers becomes increasingly vital in ensuring the availability of innovative diagnostic tools that address pressing health concerns.

Restraints in the IVD Contract Manufacturing Market

The IVD contract manufacturing market encounters notable challenges associated with costs. The process of developing and producing in vitro diagnostic devices demands substantial financial investments in research, regulatory compliance, and manufacturing infrastructure. Such elevated expenses can serve as a barrier for small and medium-sized enterprises, making it difficult for them to enter the market and hindering overall growth in the industry. Consequently, the financial burden of innovation and production capabilities may limit competition and the introduction of new technologies, affecting the market dynamics and potential advancements within the IVD sector.

Market Trends of the IVD Contract Manufacturing Market

The IVD Contract Manufacturing market is witnessing a significant trend towards outsourcing production to emerging markets, particularly in the Asia-Pacific region. Companies are increasingly attracted to these areas due to lower labor costs and the availability of skilled personnel, which facilitate efficient manufacturing processes. This shift not only helps reduce operational expenses but also allows manufacturers to leverage the burgeoning demand for in vitro diagnostic products in these fast-growing markets. As a result, the focus on cost-effective production solutions and access to a skilled workforce is reshaping the landscape of the IVD industry, driving growth and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
Market Attractiveness Index
Supply Chain Analysis
Pricing Analysis

Global IVD Contract Manufacturing Market Size by Product Type & CAGR (2026-2033)

Market Overview
Consumables
Equipment

Global IVD Contract Manufacturing Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunoassays
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation & Hemostasis
Other Technologies

Global IVD Contract Manufacturing Market Size by Service Type & CAGR (2026-2033)

Market Overview
Manufacturing Services
Assay Development
Other Services

Global IVD Contract Manufacturing Market Size & CAGR (2026-2033)

North America, (Product Type, Technology, Service Type)
- US
- Canada
Europe, (Product Type, Technology, Service Type)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product Type, Technology, Service Type)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product Type, Technology, Service Type)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product Type, Technology, Service Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanmina Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TE Connectivity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celestica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Savyon Diagnostics, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KMC Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cenogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cone Bioproducts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimball Electronics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratec SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujirebio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biokit (Werfen)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments